BR
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Wasatch Advisors LP
· Reduced
−$83M
Change
−4.1M
Date
Q1 2026
|
Wasatch Advisors LP | Reduced· Q1 2026 | −$83M | −4.1M | – | Q1 2026 | |||||
|
Two Sigma Investments, LP
· Added
+$58M
Change
+2.9M
Δ Own
+675.5%
Date
Q1 2026
|
Two Sigma Investments, LP | Added· Q1 2026 | +$58M | +2.9M | +675.5% | Q1 2026 | |||||
|
Citadel Advisors LLC
· Added
+$48M
Change
+2.4M
Δ Own
+340.7%
Date
Q1 2026
|
Citadel Advisors LLC | Added· Q1 2026 | +$48M | +2.4M | +340.7% | Q1 2026 | |||||
|
Woodline Partners LP
· Reduced
−$46M
Change
−2.3M
Date
Q1 2026
|
Woodline Partners LP | Reduced· Q1 2026 | −$46M | −2.3M | – | Q1 2026 | |||||
|
Diamond Hill Capital Management Inc
· New
+$42M
Change
+2.1M
Date
Q1 2026
|
Diamond Hill Capital Management Inc | New· Q1 2026 | +$42M | +2.1M | – | Q1 2026 | |||||
|
Point72 Asset Management, L.P.
· Reduced
−$39M
Change
−1.9M
Δ Own
−67.2%
Date
Q1 2026
|
Point72 Asset Management, L.P. | Reduced· Q1 2026 | −$39M | −1.9M | −67.2% | Q1 2026 | |||||
|
Alyeska Investment Group, L.P.
· Reduced
−$35M
Change
−1.7M
Date
Q1 2026
|
Alyeska Investment Group, L.P. | Reduced· Q1 2026 | −$35M | −1.7M | – | Q1 2026 | |||||
|
AQR Capital Management LLC
· Added
+$31M
Change
+1.5M
Date
Q1 2026
|
AQR Capital Management LLC | Added· Q1 2026 | +$31M | +1.5M | – | Q1 2026 | |||||
|
Yacktman Asset Management LP
· New
+$30M
Change
+1.5M
Date
Q1 2026
|
Yacktman Asset Management LP | New· Q1 2026 | +$30M | +1.5M | – | Q1 2026 | |||||
|
Holocene Advisors, LP
· New
+$30M
Change
+1.5M
Date
Q1 2026
|
Holocene Advisors, LP | New· Q1 2026 | +$30M | +1.5M | – | Q1 2026 | |||||
|
Amundi
· Added
+$24M
Change
+1.2M
Date
Q1 2026
|
Amundi | Added· Q1 2026 | +$24M | +1.2M | – | Q1 2026 | |||||
|
Philosophy Capital Management LLC
· New
+$23M
Change
+1.1M
Date
Q1 2026
|
Philosophy Capital Management LLC | New· Q1 2026 | +$23M | +1.1M | – | Q1 2026 | |||||
|
Voloridge Investment Management, LLC
· Exited
−$22M
Change
−1.1M
Δ Own
−100.0%
Date
Q1 2026
|
Voloridge Investment Management, LLC | Exited· Q1 2026 | −$22M | −1.1M | −100.0% | Q1 2026 | |||||
|
UBS Group AG
· Added
+$22M
Change
+1.1M
Date
Q1 2026
|
UBS Group AG | Added· Q1 2026 | +$22M | +1.1M | – | Q1 2026 | |||||
|
Janus Henderson Group PLC
· Reduced
−$21M
Change
−1.0M
Date
Q1 2026
|
Janus Henderson Group PLC | Reduced· Q1 2026 | −$21M | −1.0M | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Finkelstein David Isaiah
· Director
Grant (A)
$32K
|
Finkelstein David Isaiah | Director | Grant (A) | $12.94 | 2K | $32K | 4K | – | Jul 1, 2026 | Jul 6, 2026 | |||||||||
|
Stein Elliot Jr
· Director
Grant (A)
$6K
|
Stein Elliot Jr | Director | Grant (A) | $12.94 | 489 | $6K | 3K | – | Jul 1, 2026 | Jul 6, 2026 | |||||||||
|
Vitale Robert V
· Director
Grant (A)
$58K
|
Vitale Robert V | Director | Grant (A) | $12.94 | 5K | $58K | 14K | – | Jul 1, 2026 | Jul 6, 2026 | |||||||||
|
Johnson Jennifer Kuperman
· Director
Grant (A)
$31K
|
Johnson Jennifer Kuperman | Director | Grant (A) | $12.94 | 2K | $31K | 22K | – | Jul 1, 2026 | Jul 6, 2026 | |||||||||
|
Conway Shawn
· Director
Grant (A)
$33K
|
Conway Shawn | Director | Grant (A) | $12.94 | 3K | $33K | 10K | – | Jul 1, 2026 | Jul 6, 2026 | |||||||||
|
Nwamu Chonda J.
· Director
Grant (A)
$32K
|
Nwamu Chonda J. | Director | Grant (A) | $12.94 | 2K | $32K | 14K | – | Jul 1, 2026 | Jul 6, 2026 | |||||||||
|
Erickson Thomas P.
· Director
Grant (A)
$47K
|
Erickson Thomas P. | Director | Grant (A) | $12.94 | 4K | $47K | 29K | – | Jul 1, 2026 | Jul 6, 2026 | |||||||||
|
Finkelstein David Isaiah
· Director
Buy
+$37K
|
Finkelstein David Isaiah | Director | Buy | $9.23 | +4K | +$37K | 13K | – | May 13, 2026 | May 14, 2026 | |||||||||
|
Vitale Robert V
· Director
Grant (A)
$58K
|
Vitale Robert V | Director | Grant (A) | $16.09 | 4K | $58K | 9K | – | Mar 31, 2026 | Apr 2, 2026 | |||||||||
|
Nwamu Chonda J.
· Director
Grant (A)
$32K
|
Nwamu Chonda J. | Director | Grant (A) | $16.09 | 2K | $32K | 12K | – | Mar 31, 2026 | Apr 2, 2026 | |||||||||
|
Finkelstein David Isaiah
· Director
Grant (A)
$32K
|
Finkelstein David Isaiah | Director | Grant (A) | $16.09 | 2K | $32K | 2K | – | Mar 31, 2026 | Apr 2, 2026 | |||||||||
|
Conway Shawn
· Director
Grant (A)
$33K
|
Conway Shawn | Director | Grant (A) | $16.09 | 2K | $33K | 7K | – | Mar 31, 2026 | Apr 2, 2026 | |||||||||
|
Johnson Jennifer Kuperman
· Director
Grant (A)
$31K
|
Johnson Jennifer Kuperman | Director | Grant (A) | $16.09 | 2K | $31K | 20K | – | Mar 31, 2026 | Apr 2, 2026 | |||||||||
|
Stein Elliot Jr
· Director
Grant (A)
$6K
|
Stein Elliot Jr | Director | Grant (A) | $16.09 | 394 | $6K | 2K | – | Mar 31, 2026 | Apr 2, 2026 | |||||||||
|
Erickson Thomas P.
· Director
Grant (A)
$47K
|
Erickson Thomas P. | Director | Grant (A) | $16.09 | 3K | $47K | 25K | – | Mar 31, 2026 | Apr 2, 2026 | |||||||||
438 reporting institutions disclosed BRBR position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.